Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study
Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study
Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study
Submitted by
admin
on May 9, 2011 - 6:48pm
Source:
Yahoo/AP
News Tags:
JNJ
ulcerative colitis
Remicade
Headline:
Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study
Do Not Allow Advertisers to Use My Personal information
